Download FREE Sample
Table of Contents
- Introduction
- Introduction
- Market Scope
- Market Definition
- Segments Covered
- Regional Segmentation
- Research Timeframe
- Currency Considered
- Study Limitations
- Stakeholders
- List of Abbreviations
- Key Conferences and Events (2025-2026)
- Research Methodology
- Secondary Research
- Primary Research
- Market Estimation
- Bottom-Up Approach
- Top-Down Approach
- Market Forecasting
- Executive Summary
- Lung Cancer Diagnostics Market Snapshot (2025-2030)
- Segment Overview
- Regional Snapshot
- Competitive Insights
- Market Overview
- Market Dynamics
- Drivers
- Rising prevalence of lung cancer globally
- Advancements in molecular diagnostics and liquid biopsy
- Increasing adoption of precision medicine for targeted therapies
- Growing awareness of early detection and government screening initiatives
- Improved healthcare access in emerging markets
- Restraints
- Complex regulatory landscape
- High costs of advanced diagnostic tools
- Variability in test accuracy and diagnostic outcomes across different platforms
- Opportunities
- Rising demand for non-invasive diagnostic methods like liquid biopsy
- Development of AI-based tools enhancing imaging diagnostics (e.g., CT scans)
- Increasing research collaborations to develop novel biomarker-based diagnostics
- Growth in personalized medicine and companion diagnostics
- Key Market Trends
- Growing adoption of NGS for comprehensive lung cancer genomic profiling
- Rising role of companion diagnostics in targeted therapies for biomarkers like EGFR, ALK, and HER2
- Unmet Market Needs
- Industry Speaks
- Global Lung Cancer Diagnostics Market Size & Forecast (2023-2030), By Cancer Type, USD Million
- Introduction
- Non-small Cell Lung Cancer
- Small Cell Lung Cancer
- Global Lung Cancer Diagnostics Market Size & Forecast (2023-2030), By Test Type, USD Million
- Introduction
- CA Test
- HER2 Test
- ALK Test
- Angiogenesis Inhibitors
- EGFR Mutation Test
- KRAS Mutation Test
- Global Lung Cancer Diagnostics Market Size & Forecast (2023-2030), By End-user, USD Million
- Introduction
- Hospitals
- Diagnostic Centers
- Others
- Global Lung Cancer Diagnostics Market Size & Forecast (2023-2030), By Region, USD Million
- Introduction
- North America Lung Cancer Diagnostics Market Size & Forecast (2023-2030), By Country, USD Million
- US
- Market Size & Forecast, By Cancer Type (USD Million)
- Market Size & Forecast, By Test Type (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- Canada
- Market Size & Forecast, By Cancer Type (USD Million)
- Market Size & Forecast, By Test Type (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- US
- Europe Lung Cancer Diagnostics Market Size & Forecast (2023-2030), By Country, USD Million
- UK
- Market Size & Forecast, By Cancer Type (USD Million)
- Market Size & Forecast, By Test Type (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- Germany
- Market Size & Forecast, By Cancer Type (USD Million)
- Market Size & Forecast, By Test Type (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- France
- Market Size & Forecast, By Cancer Type (USD Million)
- Market Size & Forecast, By Test Type (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- Italy
- Market Size & Forecast, By Cancer Type (USD Million)
- Market Size & Forecast, By Test Type (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- Spain
- Market Size & Forecast, By Cancer Type (USD Million)
- Market Size & Forecast, By Test Type (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- Rest of Europe
- Market Size & Forecast, By Cancer Type (USD Million)
- Market Size & Forecast, By Test Type (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- UK
- Asia Pacific (APAC) Lung Cancer Diagnostics Market Size & Forecast (2023-2030), By Country, USD Million
- China
- Market Size & Forecast, By Cancer Type (USD Million)
- Market Size & Forecast, By Test Type (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- Japan
- Market Size & Forecast, By Cancer Type (USD Million)
- Market Size & Forecast, By Test Type (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- India
- Market Size & Forecast, By Cancer Type (USD Million)
- Market Size & Forecast, By Test Type (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- Rest of Asia Pacific
- Market Size & Forecast, By Cancer Type (USD Million)
- Market Size & Forecast, By Test Type (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- China
- Latin America (LATAM) Lung Cancer Diagnostics Market Size & Forecast (2023-2030), USD Million
- Market Size & Forecast, By Cancer Type (USD Million)
- Market Size & Forecast, By Test Type (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- Middle East & Africa (MEA) Lung Cancer Diagnostics Market Size & Forecast (2023-2030), USD Million
- Market Size & Forecast, By Cancer Type (USD Million)
- Market Size & Forecast, By Test Type (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- Competitive Landscape
- Key Players and their Competitive Positioning
- Key Player Comparison
- Segment-wise Player Mapping
- Market Share Analysis (2024)
- Company Categorization Matrix
- Dominants/Leaders
- New Entrants
- Emerging Players
- Innovative Players
- Key Strategies Assessment, By Player (2022-2024)
- New Product Launches
- Partnerships, Agreements, & Collaborations
- Mergers & Acquisitions
- Geographic Expansion
- Key Players and their Competitive Positioning
- Company Profiles*
(Business Overview, Financial Performance**, Products Offered, Recent Developments)
- Hoffmann-La Roche Ltd
- Thermo Fisher Scientific
- Agilent Technologies
- Qiagen
- Abbott
- Bio-Rad Laboratories, Inc.
- Neogenomics Laboratories
- Myriad Genetics, Inc.
- Illumina Inc.
- Other Prominent Players
Note: *Indicative list
**For listed companies
